Wendy's rejects $1.4 billion Trian buyout, adopts 'poison pill' defense
Photo: CrexiWendy's has rejected a $1.4 billion buyout offer from an investor group led by activist investor Nelson Peltz's Trian Fund Management, saying the $7.35-a-share cash bid "substantially undervalues" the Dublin-based burger chain — and adopted a one-year shareholder rights plan, known as a "poison pill," to guard against a hostile takeover.
The company announced the decision on Thursday, a week after the Trian-led group made its unsolicited, non-binding proposal to buy all of the Wendy's shares it does not already own and take the company private. A committee of independent directors, unaffiliated with Trian, unanimously rejected the offer after evaluating it with financial and legal advisers.
"The Independent Committee thoroughly evaluated this Proposal and unanimously concluded that it substantially undervalues Wendy's standalone prospects and long-term earnings potential," board chairman Art Winkleblack said in a statement. The committee said the offer is not in the best interests of Wendy's and its shareholders.
Alongside the rejection, Wendy's board adopted the limited-duration shareholder rights plan on Wednesday, November 4. The plan, which runs until November 3, 2027, would let shareholders other than a would-be acquirer buy additional stock at a discount if any individual or group accumulates 15 percent or more of the company's shares without board approval — making a hostile takeover far more expensive. Wendy's said the plan was adopted after the investor group rejected a standstill agreement that would have paused further share purchases.
The Trian-led group already owns about 16.3 percent of Wendy's, according to a regulatory filing. Besides Trian, the group includes restaurant operator Flynn Group, one of Wendy's largest franchisees, and investment firms BlueFive Capital and Sixth Street Partners. Trian declined to comment on the rejection. Peltz, a former Wendy's chairman, has long been one of the chain's largest shareholders, and Trian president Peter May has served as a Wendy's director since 2008.
The rejection came as Wendy's reported third-quarter results on Thursday. Sales came in below what analysts had forecast, but earnings beat expectations, and shares rose about 1 percent to roughly $7.75. The $7.35-a-share offer had carried a premium of about 20 percent when it was made, based on the stock's close the day before it surfaced.
Chief Executive Bob Wright, who joined the company in May, said the board is confident in the turnaround plan he launched this year, called "Dave's Way" after founder Dave Thomas. The plan includes thicker, crispier bacon, a richer and creamier Frosty, whole-leaf lettuce on sandwiches and improved salads, and makes serving breakfast optional at U.S. restaurants so operators can focus on the items customers want most. "We're confident that we have the right strategy, execution and resources to restore Wendy's to its full potential and drive meaningful shareholder value," Wright said on the earnings call.
The chain has been under pressure for months. About three months ago, Wendy's withdrew its annual forecast and cut its dividend, and it has been grappling with high beef prices and aging stores. Founded by Dave Thomas in Columbus in 1969 and now headquartered in Dublin, the company operates more than 7,000 restaurants worldwide, and its stock is down nearly 25 percent so far this year.
With the poison pill in place, Trian must now decide whether to sweeten its offer, stage a proxy fight, or get behind Wright's turnaround attempt, analysts said. Wendy's said it does not plan further comment on the bid unless more disclosure is required.
Sources: Reuters, "Wendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan" (Nov. 5, 2026); The Associated Press, "Wendy's rejects buyout bid and girds itself for a hostile takeover campaign" (Nov. 5, 2026); USA Today, "Wendy's refreshing menu in 2027 with thicker bacon, creamier Frosty" (Nov. 6, 2026); The Wall Street Journal, "Wendy's Rejects Trian's $1.4 Billion Takeover Offer" (Nov. 5, 2026).
Sponsored